AstraZeneca
AZN
#58
Rank
$227.83 B
Marketcap
$71.10
Share price
0.18%
Change (1 day)
-10.35%
Change (1 year)

Revenue for AstraZeneca (AZN)

Revenue in 2025 (TTM): $54.98 Billion USD

According to AstraZeneca's latest financial reports the company's current revenue (TTM ) is $54.98 Billion USD. In 2024 the company made a revenue of $54.07 Billion USD an increase over the revenue in the year 2023 that were of $45.81 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AstraZeneca from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $54.98 B1.68%
2024 $54.07 B18.03%
2023 $45.81 B3.29%
2022 $44.35 B18.53%
2021 $37.41 B40.58%
2020 $26.61 B9.16%
2019 $24.38 B10.38%
2018 $22.09 B-1.67%
2017 $22.46 B-2.33%
2016 $23.00 B-6.9%
2015 $24.70 B-6.81%
2014 $26.51 B3.12%
2013 $25.71 B-8.09%
2012 $27.97 B-16.72%
2011 $33.59 B0.97%
2010 $33.26 B1.42%
2009 $32.80 B3.81%
2008 $31.60 B6.91%
2007 $29.55 B11.65%
2006 $26.47 B10.54%
2005 $23.95 B11.78%
2004 $21.42 B13.67%
2003 $18.84 B6.82%
2002 $17.64 B-25.02%
2001 $23.53 B29.9%
2000 $18.11 B-1.74%
1999 $18.43 B87.63%
1998 $9.82 B9.72%
1997 $8.95 B-21.63%
1996 $11.42 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Bristol-Myers Squibb
BMY
$47.63 B-13.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$62.46 B 13.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$63.92 B 16.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$40.60 B-26.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$47.43 B-13.73%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
$49.00 B-10.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$89.33 B 62.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$42.34 B-22.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$9.81 B-82.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$53.22 B-3.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland